SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-08-037007
Filing Date
2008-06-05
Accepted
2008-06-05 14:04:18
Documents
1
Period of Report
2008-06-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd209897.html 4  
1 FORM 4 rrd209897.xml 4 26588
  Complete submission text file 0001181431-08-037007.txt   28397
Mailing Address 2400 BAYSHORE PARKWAY, SUITE 200 MOUNTAIN VIEW CA 94043
Business Address 2400 BAYSHORE PARKWAY, SUITE 200 MOUNTAIN VIEW CA 94043 650-386-3100
MAP Pharmaceuticals, Inc. (Issuer) CIK: 0001401923 (see all company filings)

IRS No.: 200507047 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 2400 BAYSHORE PARKWAY SUITE 200 MOUNTAIN VIEW CA 94043
Business Address (650) 386-3100
GIANAKAKOS ANASTASIOS (Reporting) CIK: 0001413822 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33719 | Film No.: 08882629